Avantor Results Presentation Deck

Core organic growth trend (Quarterly) (Dollars in millions) Total Avantor, Global GAAP consolidated net sales Core organic growth (decline) End market Biopharma Healthcare Education & Government Advanced tech & applied materials Product Proprietary materials & consumables Third-party materials & consumables Services & specialty procurement Equipment & instrumentation Navantor™ 1Q22 $1,950 7.3% +HSD +MSD -LSD +HSD +DD +LSD +LSD +HSD 2Q22 $1,911 6.4% +HSD - LSD - LSD +DD +DD +MSD +LSD +MSD 3Q22 $1,857 7.8% +HSD +MSD -LSD +DD +DD +LSD +MSD +LSD 4Q22 $1,795 2.7% +LSD -MSD -LSD +HSD +HSD -MSD -LSD +LSD 1Q23 $1,780 (1.8%) -LSD -MSD +MSD -LSD +/- 0 -MSD +MSD -LSD Note: LSD 1-3% / MSD 4-6% / HSD 7-9% / LDD 10-12%. Organic growth (decline) is reported revenue growth (decline) excluding the impacts from changes in foreign currency exchange rates. Core organic growth (decline) is organic growth (decline) net of COVID-19 impact. 2Q23 $1,744 (6.5%) -HSD +MSD +MSD -HSD -DD -MSD +MSD -MSD 3Q23 $1,720 (7.9%) -HSD -HSD +LSD -LDD -LDD -HSD +MSD -HSD 12

View entire presentation